William Charles Doerrler

Array ( [id] => 3496559 [patent_doc_number] => 05508414 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-04-16 [patent_title] => '.alpha.-methylene-5-thiazolacetic acid esters' [patent_app_type] => 1 [patent_app_number] => 8/342337 [patent_app_country] => US [patent_app_date] => 1994-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5952 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/508/05508414.pdf [firstpage_image] =>[orig_patent_app_number] => 342337 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3661948 [patent_doc_number] => 05656637 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-08-12 [patent_title] => 'Thiazole derivatives' [patent_app_type] => 1 [patent_app_number] => 8/334378 [patent_app_country] => US [patent_app_date] => 1994-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3798 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 124 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/656/05656637.pdf [firstpage_image] =>[orig_patent_app_number] => 334378 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3622687 [patent_doc_number] => 05594002 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-01-14 [patent_title] => 'Benzazabicyclic carbamates as novel cholinesterase inhibitors' [patent_app_type] => 1 [patent_app_number] => 8/328205 [patent_app_country] => US [patent_app_date] => 1994-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8634 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 727 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/594/05594002.pdf [firstpage_image] =>[orig_patent_app_number] => 328205 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3698685 [patent_doc_number] => 05677322 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-10-14 [patent_title] => 'Maillard reaction inhibitor' [patent_app_type] => 1 [patent_app_number] => 8/325233 [patent_app_country] => US [patent_app_date] => 1994-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30473 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/677/05677322.pdf [firstpage_image] =>[orig_patent_app_number] => 325233 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3658462 [patent_doc_number] => 05656401 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-08-12 [patent_title] => 'Electroluminescent device comprising oxadiazole compounds luminescent material, oxadiazole compounds for the device, and method of producing oxadiazole compounds' [patent_app_type] => 1 [patent_app_number] => 8/321765 [patent_app_country] => US [patent_app_date] => 1994-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 15 [patent_no_of_words] => 15450 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 153 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/656/05656401.pdf [firstpage_image] =>[orig_patent_app_number] => 321765 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3614298 [patent_doc_number] => 05510359 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-04-23 [patent_title] => 'Heteroaromatic 5-hydroxytryptamine receptor agonists' [patent_app_type] => 1 [patent_app_number] => 8/318610 [patent_app_country] => US [patent_app_date] => 1994-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7831 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/510/05510359.pdf [firstpage_image] =>[orig_patent_app_number] => 318610 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3615427 [patent_doc_number] => 05534630 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-07-09 [patent_title] => 'Biologically active initiators for radical polymerization' [patent_app_type] => 1 [patent_app_number] => 8/320597 [patent_app_country] => US [patent_app_date] => 1994-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4552 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 269 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/534/05534630.pdf [firstpage_image] =>[orig_patent_app_number] => 320597 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3113286 [patent_doc_number] => 05464849 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-11-07 [patent_title] => 'N-hydroxyurea derivatives as antiallergy and antiinflammatory agents' [patent_app_type] => 1 [patent_app_number] => 8/318180 [patent_app_country] => US [patent_app_date] => 1994-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4440 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/464/05464849.pdf [firstpage_image] =>[orig_patent_app_number] => 318180 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3634362 [patent_doc_number] => 05610182 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-03-11 [patent_title] => 'Pharmaceutical composition for the therapy of cerebral thrombosis' [patent_app_type] => 1 [patent_app_number] => 8/313244 [patent_app_country] => US [patent_app_date] => 1994-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11635 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 153 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/610/05610182.pdf [firstpage_image] =>[orig_patent_app_number] => 313244 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3526459 [patent_doc_number] => 05541168 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-07-30 [patent_title] => 'Substituted 2-(phosphinyloxymethyl)-1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof' [patent_app_type] => 1 [patent_app_number] => 8/348411 [patent_app_country] => US [patent_app_date] => 1994-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10740 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/541/05541168.pdf [firstpage_image] =>[orig_patent_app_number] => 348411 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3623981 [patent_doc_number] => 05607936 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-03-04 [patent_title] => 'Substituted aryl piperazines as neurokinin antagonists' [patent_app_type] => 1 [patent_app_number] => 8/316013 [patent_app_country] => US [patent_app_date] => 1994-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23689 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/607/05607936.pdf [firstpage_image] =>[orig_patent_app_number] => 316013 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3587452 [patent_doc_number] => 05552423 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-09-03 [patent_title] => 'Isothiazolone derivative and microbicidal composition comprising the same as active ingredient' [patent_app_type] => 1 [patent_app_number] => 8/312962 [patent_app_country] => US [patent_app_date] => 1994-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3295 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/552/05552423.pdf [firstpage_image] =>[orig_patent_app_number] => 312962 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4422201 [patent_doc_number] => 06225347 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-01 [patent_title] => '9-halogen-(Z)-prostaglandin derivatives, process for their production and their use as pharmaceutical agents' [patent_app_type] => 1 [patent_app_number] => 8/313667 [patent_app_country] => US [patent_app_date] => 1994-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6555 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 546 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/225/06225347.pdf [firstpage_image] =>[orig_patent_app_number] => 313667 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3614204 [patent_doc_number] => 05534547 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-07-09 [patent_title] => 'Prostaglandins of the D series, and tranquilizers and soporifics containing the same' [patent_app_type] => 1 [patent_app_number] => 8/310109 [patent_app_country] => US [patent_app_date] => 1994-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 27 [patent_no_of_words] => 11453 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/534/05534547.pdf [firstpage_image] =>[orig_patent_app_number] => 310109 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3571946 [patent_doc_number] => 05538991 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-07-23 [patent_title] => 'Endothelin antagonists bearing 5-membered heterocyclic amides' [patent_app_type] => 1 [patent_app_number] => 8/306275 [patent_app_country] => US [patent_app_date] => 1994-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27977 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 400 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/538/05538991.pdf [firstpage_image] =>[orig_patent_app_number] => 306275 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3603194 [patent_doc_number] => 05578621 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-11-26 [patent_title] => 'Benzamide derivatives' [patent_app_type] => 1 [patent_app_number] => 8/301407 [patent_app_country] => US [patent_app_date] => 1994-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 1068 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/578/05578621.pdf [firstpage_image] =>[orig_patent_app_number] => 301407 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3629343 [patent_doc_number] => 05686487 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-11-11 [patent_title] => 'Treatment of cataract with 15-keto-prostaglandin compounds' [patent_app_type] => 1 [patent_app_number] => 8/300541 [patent_app_country] => US [patent_app_date] => 1994-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14271 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 177 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/686/05686487.pdf [firstpage_image] =>[orig_patent_app_number] => 300541 [rel_patent_id] =>[rel_patent_doc_number] =>)